26 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Papillomavirus Infections ... Women with in HIV-AIDS ... infection ... IDSA #Prevention #Treatment ... #HIVAIDS #pharmacology
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Summary Acute AIDP ... Epidemiology: • 1-2 cases ... response preceding infection ... Campylobacter jejuni - HIV ... #neurology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... in HIV-AIDS Preventing ... Treating Acute Infection ... IDSA #Prevention #Treatment ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Bacterial Enteric Infections ... in HIV-AIDS Preventing ... • In rare cases ... IDSA #Prevention #Treatment ... #HIVAIDS #pharmacology
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
HIV / AIDS - Differential ... Antimicrobial treatment ... status, and focal neurologic ... Demyelinating disease caused ... differential #diagnosis #AIDS
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
) Infections in ... HIV-AIDS Treating ... • Continue treatment ... IDSA #Prevention #Treatment ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Trypanosomiasis) in HIV-AIDS ... duration same as for treatment ... Disease Note: Treatment ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... for effective treatment ... IDSA #Prevention #Treatment ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
Coccidiodomycosis in HIV-AIDS ... Treating Mild Infections ... with positive serology ... IDSA #Prevention #Treatment ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Isospora belli Infection ... in HIV-AIDS Treating ... Isospora belli Infection ... IDSA #Prevention #Treatment ... #HIVAIDS #pharmacology